{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:37Z","timestamp":1787761957416,"version":"build-2784847793"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RS2022-04"],"award-info":[{"award-number":["RS2022-04"]}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z191100006619111"],"award-info":[{"award-number":["Z191100006619111"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10067-024-07267-x","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:58:39Z","timestamp":1736863119000},"page":"583-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Refractory psoriatic arthritis: emerging concepts in whole process management"],"prefix":"10.1007","volume":"44","author":[{"given":"Haojie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5444-3435","authenticated-orcid":false,"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"1","key":"7267_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W et al (2021) Psoriatic arthritis. Nat Rev Dis Primers 7(1):59","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"7267_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15015","volume":"27","author":"R Yao","year":"2024","unstructured":"Yao R, Huo A-P, Jia Y, Su Y (2024) Psoriatic arthritis: Overcoming the obstacles of early diagnosis and optimal management. Int J Rheum Dis 27(1):e15015","journal-title":"Int J Rheum Dis"},{"issue":"10136","key":"7267_CR3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273\u20132284","journal-title":"Lancet"},{"issue":"2","key":"7267_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","volume":"73","author":"AP Villani","year":"2015","unstructured":"Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard M-A et al (2015) Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. J Am Acad Dermatol 73(2):242\u2013248","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"7267_CR5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/1756-185X.14805","volume":"26","author":"C Lu","year":"2023","unstructured":"Lu C, Yang F, Liu H, Dou L, Wang Y, Li H et al (2023) Chinese Registry of Psoriatic Arthritis (CREPAR): I Clinical characteristics of Chinese patients with psoriatic arthritis. Int J Rheum Dis. 26(9):1737\u201344","journal-title":"Int J Rheum Dis."},{"issue":"8","key":"7267_CR6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/rheumatology\/keaa030","volume":"59","author":"B Hag\u00e8ge","year":"2020","unstructured":"Hag\u00e8ge B, Tan E, Gayraud M, Fautrel B, Gossec L, Mitrovic S (2020) Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis. Rheumatology (Oxford) 59(8):1818\u20131825","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"7267_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40744-023-00574-w","volume":"10","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, Perrotta FM (2023) Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis. Rheumatol Ther 10(5):1119\u20131125","journal-title":"Rheumatol Ther"},{"issue":"1","key":"7267_CR8","doi-asserted-by":"publisher","first-page":"e003809","DOI":"10.1136\/rmdopen-2023-003809","volume":"10","author":"S Singla","year":"2024","unstructured":"Singla S, Ribeiro A, Torgutalp M, Mease PJ, Proft F (2024) Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project. RMD Open. 10(1):e003809","journal-title":"RMD Open."},{"issue":"9","key":"7267_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard-2023-224148","volume":"82","author":"A Zabotti","year":"2023","unstructured":"Zabotti A, De Marco G, Gossec L, Baraliakos X, Aletaha D, Iagnocco A et al (2023) EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Ann Rheum Dis 82(9):1162\u20131170","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7267_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40744-022-00461-w","volume":"9","author":"FM Perrotta","year":"2022","unstructured":"Perrotta FM, Scriffignano S, Ciccia F, Lubrano E (2022) Clinical Characteristics of Potential \u201cDifficult-to-treat\u201d Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatol Ther 9(4):1193\u20131201","journal-title":"Rheumatol Ther"},{"issue":"1","key":"7267_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","volume":"80","author":"G Nagy","year":"2021","unstructured":"Nagy G, Roodenrijs NM, Welsing PM, Kedves M, Hamar A, van der Goes MC et al (2021) EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 80(1):31\u201335","journal-title":"Ann Rheum Dis"},{"key":"7267_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152275","volume":"63","author":"C Philippoteaux","year":"2023","unstructured":"Philippoteaux C, Marty-Ane A, Cailliau E, Labreuche J, Philippe P, Cortet B et al (2023) Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis. Semin Arthritis Rheum 63:152275","journal-title":"Semin Arthritis Rheum"},{"key":"7267_CR13","doi-asserted-by":"publisher","unstructured":"Graceffa D, Sperati F, Lora V, Orsini D, Spoletini G, Bonifati C (2024) Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis. J Eur Acad Dermatol Venereol.https:\/\/doi.org\/10.1111\/jdv.20182","DOI":"10.1111\/jdv.20182"},{"issue":"3","key":"7267_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/ard-2023-225087","volume":"83","author":"H Marzo-Ortega","year":"2024","unstructured":"Marzo-Ortega H, Harrison SR, Nagy G, Machado PM, McGonagle DG, Aydin SZ et al (2024) Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey. Ann Rheum Dis 83(3):403\u2013404","journal-title":"Ann Rheum Dis"},{"key":"7267_CR15","doi-asserted-by":"publisher","unstructured":"Vassilakis KD, Papagoras C, Fytanidis N, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Boumpas D, Katsimpri P, Katsifis-Nezis D, Dimitroulas T, Kougkas N, Boutel M, Sfikakis PP, Tektonidou MG, Gialouri C, Bogdanos D, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E,Klavdianou K, Grika EP, Sfontouris C, Daoussis D, Iliopoulos G, Bournazos I, Karokis D, Georganas K, Patrikos D, Vassilopoulos D, Fragoulis GE (2024) Identification and characteristics of patients with potential difficult-to-treat Psoriatic Arthritis: exploratory analyses of the Greek PsA registry. Rheumatology (Oxford). 63(9):2427\u20132432.\u00a0https:\/\/doi.org\/10.1093\/rheumatology\/keae263","DOI":"10.1093\/rheumatology\/keae263"},{"issue":"3","key":"7267_CR16","first-page":"074","volume":"8","author":"AL Ribeiro","year":"2024","unstructured":"Ribeiro AL, Singla S, Chandran V, Chronis N, Liao W, Lindsay C et al (2024) Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals. Rheumatol Adv Pract. 8(3):074","journal-title":"Rheumatol Adv Pract."},{"key":"7267_CR17","doi-asserted-by":"publisher","unstructured":"Marzo-Ortega H, Harrison SR, Nagy G, Machado PM, McGonagle DG, Aydin SZ, Almodovar-Gonz\u00e1lez R, Bautista-Molano W, Gossec L, Lubrano E, Nash P, Pimentel Santos F, Soriano ER, Siebert S (2023) Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey. Ann Rheum Dis 83(3):403\u2013404. https:\/\/doi.org\/10.1136\/ard-2023-225087","DOI":"10.1136\/ard-2023-225087"},{"issue":"3","key":"7267_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41584-024-01083-y","volume":"20","author":"S Siebert","year":"2024","unstructured":"Siebert S, Marzo-Ortega H (2024) Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow. Nat Rev Rheumatol 20(3):135\u2013136","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"7267_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.42780","volume":"76","author":"F Fagni","year":"2024","unstructured":"Fagni F, Motta F, Schett G, Selmi C (2024) Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach. Arthritis Rheumatol 76(5):670\u2013674","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"7267_CR20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10067-022-06061-x","volume":"41","author":"L Widawski","year":"2022","unstructured":"Widawski L, Fabacher T, Spielmann L, Gottenberg JE, Sibilia J, Duret PM et al (2022) Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat. Clin Rheumatol 41(5):1421\u20131429","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7267_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3899\/jrheum.170384","volume":"45","author":"RA AlJohani","year":"2018","unstructured":"AlJohani RA, Polachek A, Ye JY, Chandran V, Gladman DD (2018) Characteristic and Outcome of Psoriatic Arthritis Patients with Hyperuricemia. J Rheumatol 45(2):213\u2013217","journal-title":"J Rheumatol"},{"issue":"5","key":"7267_CR22","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10067-020-04981-0","volume":"39","author":"R Felten","year":"2020","unstructured":"Felten R, Duret P-M, Gottenberg J-E, Spielmann L, Messer L (2020) At the crossroads of gout and psoriatic arthritis: \u201cpsout.\u201d Clin Rheumatol 39(5):1405\u20131413","journal-title":"Clin Rheumatol"},{"issue":"12","key":"7267_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1346-8138.13968","volume":"44","author":"N Tsuruta","year":"2017","unstructured":"Tsuruta N, Imafuku S, Narisawa Y (2017) Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol 44(12):1349\u20131352","journal-title":"J Dermatol"},{"issue":"6","key":"7267_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/BOR.0000000000000949","volume":"35","author":"AB Maharaj","year":"2023","unstructured":"Maharaj AB, Eder L, Ogdie A (2023) The impact of dietary interventions in psoriatic arthritis. Curr Opin Rheumatol 35(6):414\u2013422","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"7267_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00296-021-04925-0","volume":"42","author":"H Kancharla","year":"2022","unstructured":"Kancharla H, Jain S, Mishra S, Acharya N, Grover S, Dogra S, Sharma A (2022) Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis. Rheumatol Int 42(3):511\u2013517","journal-title":"Rheumatol Int"},{"issue":"2","key":"7267_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/1756-185X.13987","volume":"24","author":"NA Elsawy","year":"2021","unstructured":"Elsawy NA, Helal A-MH, AbdElHamid HA, Abdel-Fattah YH (2021) Fibromyalgia in patients with psoriatic arthritis: Impact on disease activity indices, fatigue and health-related quality of life. Int J Rheum Dis 24(2):189\u201396","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"7267_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3899\/jrheum.151491","volume":"43","author":"S Brikman","year":"2016","unstructured":"Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A et al (2016) The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study. J Rheumatol 43(9):1749\u20131754","journal-title":"J Rheumatol"},{"issue":"9","key":"7267_CR28","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/jdv.19192","volume":"37","author":"U Mrowietz","year":"2023","unstructured":"Mrowietz U, S\u00fcmb\u00fcl M, Gerdes S (2023) Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol 37(9):1731\u20131738","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"7267_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/BOR.0000000000000388","volume":"29","author":"PJ Mease","year":"2017","unstructured":"Mease PJ (2017) Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 29(4):304\u2013310","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"7267_CR30","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/annrheumdis-2018-213700","volume":"77","author":"RBM Landew\u00e9","year":"2018","unstructured":"Landew\u00e9 RBM (2018) Overdiagnosis and overtreatment in rheumatology: a little caution is in order. Ann Rheum Dis 77(10):1394\u20131396","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7267_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41584-021-00747-3","volume":"18","author":"M Favero","year":"2022","unstructured":"Favero M, Belluzzi E, Ortolan A, Lorenzin M, Oliviero F, Doria A et al (2022) Erosive hand osteoarthritis: latest findings and outlook. Nat Rev Rheumatol 18(3):171\u2013183","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7267_CR32","first-page":"159","volume":"41","author":"CG Gialouri","year":"2023","unstructured":"Gialouri CG, Evangelatos G, Zhao SS, Kouna K, Karamanakos A, Iliopoulos A et al (2023) Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients\u2019 perception? Clin Exp Rheumatol 41(1):159\u2013165","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"7267_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.semarthrit.2020.02.001","volume":"50","author":"EZ Zusman","year":"2020","unstructured":"Zusman EZ, Howren AM, Park JYE, Dutz J, De Vera MA (2020) Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 50(6):1481\u20131488","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"7267_CR34","first-page":"1046","volume":"38","author":"E Calabresi","year":"2020","unstructured":"Calabresi E, Monti S, Terenzi R, Zanframundo G, Perniola S, Carli L (2020) One year in review 2019: psoriatic arthritis. Clin Exp Rheumatol 38(6):1046\u20131055","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"7267_CR35","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/ijms21051690","volume":"21","author":"M Kamata","year":"2020","unstructured":"Kamata M, Tada Y (2020) Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review. Int J Mol Sci 21(5):1690","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7267_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clinthera.2023.01.006","volume":"45","author":"A Panagiotopoulos","year":"2023","unstructured":"Panagiotopoulos A, Fragoulis GE (2023) Comorbidities in Psoriatic Arthritis: A Narrative Review. Clin Ther 45(2):177\u2013189","journal-title":"Clin Ther"},{"issue":"2","key":"7267_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101689","volume":"35","author":"H So","year":"2021","unstructured":"So H, Tam L-S (2021) Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management. Best Pract Res Clin Rheumatol 35(2):101689","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"7267_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM (2017) Psoriasis and comorbid diseases: Implications for management. J Am Acad Dermatol 76(3):393\u2013403","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"7267_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","volume":"67","author":"JU Scher","year":"2015","unstructured":"Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM et al (2015) Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 67(1):128\u2013139","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"7267_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101494","volume":"33","author":"B Myers","year":"2019","unstructured":"Myers B, Brownstone N, Reddy V, Chan S, Thibodeaux Q, Truong A et al (2019) The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol 33(6):101494","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7267_CR41","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang S-X, Zhao R, Song S, Zhang H-Y, Wang C-H, Li X-F (2024) Dysbiosis of the gut microbiota in patients with psoriatic arthritis is closely related to lymphocyte subsets and cytokines. Inflammation\u00a047(4):1220\u20131228.\u00a0https:\/\/doi.org\/10.1007\/s10753-024-01971-1","DOI":"10.1007\/s10753-024-01971-1"},{"issue":"8","key":"7267_CR42","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3390\/ijms22083998","volume":"22","author":"I Olejniczak-Staruch","year":"2021","unstructured":"Olejniczak-Staruch I, Ci\u0105\u017cy\u0144ska M, Sobolewska-Sztychny D, Narbutt J, Skibi\u0144ska M, Lesiak A (2021) Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int J Mol Sci. 22(8):3998","journal-title":"Int J Mol Sci."},{"issue":"3","key":"7267_CR43","doi-asserted-by":"publisher","first-page":"pbad023","DOI":"10.1093\/pcmedi\/pbad023","volume":"6","author":"N Yu","year":"2023","unstructured":"Yu N, Wang J, Liu Y, Guo Y (2023) Investigating the gut microbiota\u2019s influence on psoriasis and psoriatic arthritis risk: a Mendelian randomization analysis. Precis Clin Med. 6(3):pbad023","journal-title":"Precis Clin Med."},{"issue":"5","key":"7267_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","volume":"16","author":"JU Scher","year":"2020","unstructured":"Scher JU, Nayak RR, Ubeda C, Turnbaugh PJ, Abramson SB (2020) Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nat Rev Rheumatol 16(5):282\u2013292","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"7267_CR45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/rheumatology\/keac458","volume":"62","author":"J Qiao","year":"2023","unstructured":"Qiao J, Zhang S-X, Chang M-J, Cheng T, Zhang J-Q, Zhao R et al (2023) Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis. Rheumatology (Oxford) 62(3):1087\u20131096","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7267_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","volume":"19","author":"G Cozzi","year":"2023","unstructured":"Cozzi G, Scagnellato L, Lorenzin M, Savarino E, Zingone F, Ometto F et al (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nat Rev Rheumatol 19(8):503\u2013518","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7267_CR47","doi-asserted-by":"publisher","first-page":"e002781","DOI":"10.1136\/rmdopen-2022-002781","volume":"9","author":"Delm\u00e1s A De Vicente","year":"2023","unstructured":"De Vicente Delm\u00e1s A, Sanchez-Bilbao L, Calvo-R\u00edo V, Mart\u00ednez-L\u00f3pez D, Herrero-Morant A, Gal\u00edndez-Agirregoikoa E et al (2023) Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open. 9(1):e002781","journal-title":"RMD Open."},{"issue":"4","key":"7267_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1756-185X.2012.01736.x","volume":"15","author":"L Niccoli","year":"2012","unstructured":"Niccoli L, Nannini C, Cassar\u00e0 E, Kaloudi O, Susini M, Lenzetti I, Cantini F (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15(4):414\u2013418","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"7267_CR49","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.35.4.354","volume":"35","author":"JR Lambert","year":"1976","unstructured":"Lambert JR, Wright V (1976) Eye inflammation in psoriatic arthritis. Ann Rheum Dis 35(4):354\u2013356","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7267_CR50","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jamadermatol.2015.1986","volume":"151","author":"A Egeberg","year":"2015","unstructured":"Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR (2015) Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study. JAMA Dermatol 151(11):1200\u20131205","journal-title":"JAMA Dermatol"},{"issue":"5","key":"7267_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jamaophthalmol.2017.0569","volume":"135","author":"C-C Chi","year":"2017","unstructured":"Chi C-C, Tung T-H, Wang J, Lin Y-S, Chen Y-F, Hsu T-K, Wang S-H (2017) Risk of Uveitis Among People With Psoriasis: A Nationwide Cohort Study. JAMA Ophthalmol 135(5):415\u2013422","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"7267_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-015-0536-x","volume":"17","author":"MA Khan","year":"2015","unstructured":"Khan MA, Haroon M, Rosenbaum JT (2015) Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye. Curr Rheumatol Rep 17(9):59","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"7267_CR53","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bjd.12731","volume":"170","author":"E Burden-Teh","year":"2014","unstructured":"Burden-Teh E, Murphy R (2014) Psoriasis and uveitis\u2013should we be asking about eye symptoms? Br J Dermatol 170(3):756\u2013757","journal-title":"Br J Dermatol"},{"key":"7267_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","volume":"189","author":"JV Forrester","year":"2018","unstructured":"Forrester JV, Kuffova L, Dick AD (2018) Autoimmunity, Autoinflammation, and Infection in Uveitis. Am J Ophthalmol 189:77\u201385","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"7267_CR55","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1038\/s41598-017-12163-3","volume":"7","author":"YK Nakamura","year":"2017","unstructured":"Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, Rosenbaum JT, Lin P (2017) Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep 7(1):11745","journal-title":"Sci Rep"},{"issue":"6","key":"7267_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3109\/09273948.2013.815786","volume":"21","author":"S Jawad","year":"2013","unstructured":"Jawad S, Liu B, Agron E, Nussenblatt RB, Sen HN (2013) Elevated serum levels of interleukin-17A in uveitis patients. Ocul Immunol Inflamm 21(6):434\u2013439","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"7267_CR57","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/annrheumdis-2021-220420","volume":"80","author":"U Lindstr\u00f6m","year":"2021","unstructured":"Lindstr\u00f6m U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d\u2019Elia H et al (2021) Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Ann Rheum Dis 80(11):1445\u20131452","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7267_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2018.01.002","volume":"17","author":"MS Chimenti","year":"2018","unstructured":"Chimenti MS, Perricone C, Novelli L, Caso F, Costa L, Bogdanos D et al (2018) Interaction between microbiome and host genetics in psoriatic arthritis. Autoimmun Rev 17(3):276\u2013283","journal-title":"Autoimmun Rev"},{"issue":"2","key":"7267_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105476","volume":"90","author":"A Ortolan","year":"2023","unstructured":"Ortolan A, Felicetti M, Lorenzin M, Cozzi G, Ometto F, Striani G et al (2023) The impact of diet on disease activity in spondyloarthritis: A systematic literature review. Joint Bone Spine 90(2):105476","journal-title":"Joint Bone Spine"},{"issue":"7","key":"7267_CR60","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","volume":"70","author":"LA Bolte","year":"2021","unstructured":"Bolte LA, Vich Vila A, Imhann F, Collij V, Gacesa R, Peters V et al (2021) Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut 70(7):1287\u20131298","journal-title":"Gut"},{"issue":"5","key":"7267_CR61","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/advances\/nmac029","volume":"13","author":"P He","year":"2022","unstructured":"He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q (2022) Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 13(5):1628\u20131651","journal-title":"Adv Nutr"},{"issue":"6","key":"7267_CR62","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00296-019-04458-7","volume":"40","author":"F Caso","year":"2020","unstructured":"Caso F, Navarini L, Carubbi F, Picchianti-Diamanti A, Chimenti MS, Tasso M et al (2020) Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study. Rheumatol Int 40(6):951\u2013958","journal-title":"Rheumatol Int"},{"key":"7267_CR63","doi-asserted-by":"publisher","unstructured":"Gopalarathinam R, Sankar R, Zhao SS (2024) Role of anti-inflammatory diet and fecal microbiota transplant in psoriatic arthritis. Clin Ther\u00a046(7):588\u2013596.\u00a0 https:\/\/doi.org\/10.1016\/j.clinthera.2024.05.005","DOI":"10.1016\/j.clinthera.2024.05.005"},{"issue":"3","key":"7267_CR64","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","volume":"7","author":"A Kumthekar","year":"2020","unstructured":"Kumthekar A, Ogdie A (2020) Obesity and Psoriatic Arthritis: A Narrative Review. Rheumatol Ther 7(3):447\u2013456","journal-title":"Rheumatol Ther"},{"issue":"1","key":"7267_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","volume":"21","author":"E Klingberg","year":"2019","unstructured":"Klingberg E, Bilberg A, Bj\u00f6rkman S, Hedberg M, Jacobsson L, Forsblad-d\u2019Elia H et al (2019) Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther 21(1):17","journal-title":"Arthritis Res Ther"},{"key":"7267_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590749","volume":"11","author":"S Porta","year":"2020","unstructured":"Porta S, Otero-Losada M, K\u00f6lliker Frers RA, Cosentino V, Kerzberg E, Capani F (2020) Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis. Front Immunol 11:590749","journal-title":"Front Immunol"},{"issue":"9","key":"7267_CR67","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10067-023-06605-9","volume":"42","author":"A Kumthekar","year":"2023","unstructured":"Kumthekar A, Ashrafi M, Deodhar A (2023) Difficult to treat psoriatic arthritis - how should we manage? Clin Rheumatol 42(9):2251\u20132265","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7267_CR68","first-page":"324","volume":"37","author":"MP Migkos","year":"2019","unstructured":"Migkos MP, Somarakis G-P, Markatseli TE, Voulgari PV, Drosos AA (2019) Epidemiological characteristics of psoriatic arthritis. Clin Exp Rheumatol 37(2):324\u2013332","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"7267_CR69","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2478\/rir-2023-0031","volume":"4","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang F (2023) Lupus hands mimicking psoriatic arthritis. Rheumatol Immunol Res 4(4):216\u2013218","journal-title":"Rheumatol Immunol Res"},{"issue":"1","key":"7267_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000025","volume":"1","author":"DJ Veale","year":"2015","unstructured":"Veale DJ, Fearon U (2015) What makes psoriatic and rheumatoid arthritis so different? RMD Open 1(1):e000025","journal-title":"RMD Open"},{"issue":"6","key":"7267_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-021-00999-8","volume":"23","author":"DD Gladman","year":"2021","unstructured":"Gladman DD (2021) Axial Psoriatic Arthritis. Curr Rheumatol Rep 23(6):35","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"7267_CR72","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","volume":"74","author":"JF Merola","year":"2015","unstructured":"Merola JF, Wu S, Han J, Choi HK, Qureshi AA (2015) Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis 74(8):1495\u20131500","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7267_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101693","volume":"35","author":"BCK Ng","year":"2021","unstructured":"Ng BCK, Jadon DR (2021) Unmet needs in psoriatic arthritis. Best Pract Res Clin Rheumatol 35(2):101693","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"7267_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jbspin.2011.06.007","volume":"79","author":"D-D Ou\u00e9draogo","year":"2012","unstructured":"Ou\u00e9draogo D-D, Meyer O (2012) Psoriatic arthritis in Sub-Saharan Africa. Joint Bone Spine 79(1):17\u201319","journal-title":"Joint Bone Spine"},{"issue":"10136","key":"7267_CR75","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/S0140-6736(18)30949-8","volume":"391","author":"F Van den Bosch","year":"2018","unstructured":"Van den Bosch F, Coates L (2018) Clinical management of psoriatic arthritis. Lancet 391(10136):2285\u20132294","journal-title":"Lancet"},{"issue":"5","key":"7267_CR76","first-page":"1071","volume":"32","author":"SSAM Shah","year":"2016","unstructured":"Shah SSAM, Naqvi BS, Fatima M, Khaliq A, Sheikh AL, Baqar M (2016) Quality of drug stores: Storage practices & Regulatory compliance in Karachi. Pakistan Pak J Med Sci 32(5):1071\u20131076","journal-title":"Pakistan Pak J Med Sci"},{"key":"7267_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104394","volume":"148","author":"R Talotta","year":"2019","unstructured":"Talotta R, Atzeni F, Sarzi-Puttini P, Masala IF (2019) Psoriatic arthritis: From pathogenesis to pharmacologic management. Pharmacol Res 148:104394","journal-title":"Pharmacol Res"},{"issue":"1","key":"7267_CR78","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1038\/s41467-018-06672-6","volume":"9","author":"MT Patrick","year":"2018","unstructured":"Patrick MT, Stuart PE, Raja K, Gudjonsson JE, Tejasvi T, Yang J et al (2018) Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients. Nat Commun 9(1):4178","journal-title":"Nat Commun"},{"issue":"2","key":"7267_CR79","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00281-021-00843-2","volume":"43","author":"S Rahmati","year":"2021","unstructured":"Rahmati S, Li Q, Rahman P, Chandran V (2021) Insights into the pathogenesis of psoriatic arthritis from genetic studies. Semin Immunopathol 43(2):221\u2013234","journal-title":"Semin Immunopathol"},{"issue":"5","key":"7267_CR80","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.3390\/ijms24054901","volume":"24","author":"AB Azuaga","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD (2023) Psoriatic arthritis pathogenesis and targeted therapies. Int J Mol Sci 24(5):4901","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7267_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105469","volume":"90","author":"L Coates","year":"2023","unstructured":"Coates L, Gossec L (2023) The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences. Joint Bone Spine 90(1):105469","journal-title":"Joint Bone Spine"},{"issue":"7","key":"7267_CR82","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/jcm11072051","volume":"11","author":"T Hioki","year":"2022","unstructured":"Hioki T, Komine M, Ohtsuki M (2022) Diagnosis and Intervention in Early Psoriatic Arthritis. J Clin Med. 11(7):2051","journal-title":"J Clin Med."},{"key":"7267_CR83","doi-asserted-by":"publisher","first-page":"1054539","DOI":"10.3389\/fimmu.2022.1054539","volume":"13","author":"T Wirth","year":"2022","unstructured":"Wirth T, Balandraud N, Boyer L, Lafforgue P, Pham T (2022) Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. Front Immunol 13:1054539","journal-title":"Front Immunol"},{"issue":"6","key":"7267_CR84","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M et al (2020) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 79(6):700\u2013712","journal-title":"Ann Rheum Dis"},{"key":"7267_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108390","volume":"214","author":"MA Rida","year":"2020","unstructured":"Rida MA, Chandran V (2020) Challenges in the clinical diagnosis of psoriatic arthritis. Clin Immunol 214:108390","journal-title":"Clin Immunol"},{"issue":"2","key":"7267_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171757","volume":"12","author":"DM Roeleveld","year":"2017","unstructured":"Roeleveld DM, Marijnissen RJ, Walgreen B, Helsen MM, van den Bersselaar L, van de Loo FA et al (2017) Higher efficacy of anti-IL-6\/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis. PLoS ONE 12(2):e0171757","journal-title":"PLoS ONE"},{"issue":"11","key":"7267_CR87","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/rheumatology\/key173","volume":"57","author":"MC Genovese","year":"2018","unstructured":"Genovese MC, Weinblatt ME, Mease PJ, Aelion JA, Peloso PM, Chen K et al (2018) Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis. Rheumatology (Oxford) 57(11):1972\u20131981","journal-title":"Rheumatology (Oxford)"},{"key":"7267_CR88","doi-asserted-by":"publisher","first-page":"1283251","DOI":"10.3389\/fimmu.2023.1283251","volume":"14","author":"C Valero-Mart\u00ednez","year":"2023","unstructured":"Valero-Mart\u00ednez C, Urgelles JF, Sall\u00e9s M, Joven-Ib\u00e1\u00f1ez BE, de Juanes A, Ram\u00edrez J et al (2023) Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Front Immunol 14:1283251","journal-title":"Front Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07267-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:40:23Z","timestamp":1738050023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07267-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7267"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07267-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"During the preparation of this work, the authors used ChatGPT 4.0 in order to polish the language of this Article. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}